Acesso livre
Acesso livre

Saúde Pública/Medicina Humanitária

Tuberculose resistente a medicamentos – Desenvolvimentos mais recentes em epidemiologia, diagnóstico e tratamento.

14 Abr, 2022 | 17:25h

Drug resistant TB – latest developments in epidemiology, diagnostics and management – International Journal of Infectious Diseases

Conteúdos relacionados:

Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment

Randomized Trial: 9-month Treatment for Multi-drug Resistant TB is as Effective as 24-month Treatment

Canadian Tuberculosis Standards – 8th Edition.

Guideline: Treatment of Drug-Resistant Tuberculosis

NICE Guideline: Tuberculosis

The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis

Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives

Novo curso online da OMS | Epidemiologia, preparação e resposta à varíola.

14 Abr, 2022 | 17:23h

Monkeypox epidemiology, preparedness and response – OpenWHO

 

Comentário no Twitter

 

Estudo randomizado | Vacinação em dose única contra o HPV se mostrou efetiva entre mulheres jovens na África.

14 Abr, 2022 | 17:07h

Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women – NEJM Evidence

Comunicado de imprensa:

Study boosts support for single-dose HPV vaccine regimen – University of Washington

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer – World Health Organization

Conteúdo relacionado: Three-year follow-up of 2-dose versus 3-dose HPV vaccine

 

Comentário no Twitter (fio – clique para saber mais)

 

Mais dados sugerem que a variante Ômicron causa doença mais leve em comparação à variante Delta.

14 Abr, 2022 | 16:51h

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study – The Lancet

Comentário: Covid-19: Symptomatic infection with omicron variant is milder and shorter than with delta, study reports – The BMJ

Conteúdos relacionados:

Another study suggests a lower risk of hospitalization and death from infection with SARS-CoV-2 Omicron variant vs. Delta.

Perspective: Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant.

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.

Cohort Study: Incidence rates and clinical outcomes of SARS-CoV-2 infection with the Omicron and Delta variants in children younger than 5 years in the US.

[Preprint] SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.

[Preprint] Study showed reduced clinical severity of Covid-19 patients admitted to hospitals in Gauteng, South Africa, during the Omicron-dominant fourth wave – “any combination of a less-virulent virus, comorbidities, high immunity from prior infection(s) or vaccination may be important contributors to this clinical presentation”.

Early data from South Africa hints Omicron variant may cause less severe Covid, but more research is needed.

Too early to tell, but preliminary information from doctors in South Africa suggests the new Covid variant Omicron may be associated with less severe disease.

Análise estatística | Estimativa global, regional e nacional de infecções diárias e cumulativas por SARS-CoV-2 até 14/11/2021.

12 Abr, 2022 | 12:48h

Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis – The Lancet

Invited Commentary: How to interpret the total number of SARS-CoV-2 infections – The Lancet

 

Comentário no Twitter (fio – clique para saber mais)

 

Cuidado intensivo das infecções respiratórias agudas graves (adaptação para COVID-19, atualização 2022).

12 Abr, 2022 | 12:40h

Clinical care of severe acute respiratory infections – Tool kit – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo de caso-controle e teste negativo | Vacina CoronaVac mostrou-se efetiva em evitar COVID-19 grave e sintomática em gestantes no Brasil.

12 Abr, 2022 | 12:37h

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study – BMC Medicine

Perspectiva | Locais de consumo supervisionado – Uma ferramenta para reduzir o risco de mortes por overdose e doenças infecciosas em pessoas que usam drogas ilícitas.

12 Abr, 2022 | 12:13h

Supervised Consumption Sites—A Tool for Reducing Risk of Overdose Deaths and Infectious Diseases in People Who Use Illicit Drugs – JAMA (gratuito por tempo limitado)

 

Comentário no Twitter

 

Opinião | Por que demorou 2 anos para a OMS dizer que a COVID é transmitida pelo ar.

11 Abr, 2022 | 12:55h

Why the WHO took two years to say COVID is airborne – Nature

Experiências positivas no centro da atenção pós-natal.

11 Abr, 2022 | 12:54h

Putting positive experiences at the centre of postnatal care – Evidently Cochrane Blog

Diretriz original: WHO recommendations on maternal and newborn care for a positive postnatal experience.

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.